These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35140820)

  • 1. Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients.
    Weng X; YangYang ; Cai Y
    Dis Markers; 2022; 2022():5188006. PubMed ID: 35140820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-to-mesenchymal transition of circulating tumor cells and CD133 expression on predicting prognosis of thyroid cancer patients.
    Li D; Li N; Ding Y
    Mol Clin Oncol; 2022 Sep; 17(3):141. PubMed ID: 36033974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of circulating tumor cells in predicating the outcomes of patients with colorectal cancer.
    Chen K; Chen Z; Ou M; Wang J; Huang X; Wu Y; Zhong W; Yang J; Huang J; Huang M; Pan D
    Clinics (Sao Paulo); 2022; 77():100070. PubMed ID: 36087570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma.
    Gao T; Mao J; Huang J; Luo F; Lin L; Lian Y; Bin S; Zhao L; Li S
    Clinics (Sao Paulo); 2023; 78():100179. PubMed ID: 36963168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative Circulating Tumor Cells (CTCs), MCTCs, and CTC-White Blood Cells Detected by a Size-Based Platform Predict Prognosis in Renal Cell Carcinoma.
    Wang Z; Zhang P; Chong Y; Xue Y; Yang X; Li H; Wang L; Zhang Y; Chen Q; Li Z; Xue L; Li H; Chong T
    Dis Markers; 2021; 2021():9956142. PubMed ID: 34733376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical Values of Circulating Tumor Cells and T Lymphocyte Subsets in Predicting a Prognosis of Lung Cancer.
    Liu X; Yan X; Li J; Mao W; Jiang F
    Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Numbers of Circulating Tumor Cells in Thyroid Cancer Patients.
    Ehlers M; Allelein S; Schwarz F; Hautzel H; Kuebart A; Schmidt M; Haase M; Dringenberg T; Schott M
    Horm Metab Res; 2018 Aug; 50(8):602-608. PubMed ID: 30081408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing circulating tumor cells and epithelial-mesenchymal transition status of papillary thyroid carcinoma patients following thyroidectomy: a prospective cohort study.
    Yu HW; Park E; Lee JK; Kim W; Kong JH; Sunoo J; Hong SC; Choi JY
    Int J Surg; 2024 Jun; 110(6):3357-3364. PubMed ID: 38445526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer.
    Xu JY; Handy B; Michaelis CL; Waguespack SG; Hu MI; Busaidy N; Jimenez C; Cabanillas ME; Fritsche HA; Cote GJ; Sherman SI
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4461-4467. PubMed ID: 27575943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer.
    Xu Y; Ren X; Jiang T; Lv S; Gao K; Liu Y; Yan Y
    BMC Cancer; 2023 May; 23(1):475. PubMed ID: 37226235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma.
    Yu J; Wang Z; Zhang H; Wang Y; Li DQ
    World J Gastroenterol; 2021 Nov; 27(43):7546-7562. PubMed ID: 34887648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy.
    Lu G; Lu Z; Li C; Huang X; Luo Q
    Comput Math Methods Med; 2021; 2021():2294562. PubMed ID: 34777560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine therapy reduces the frequency of circulating tumour cells in patients with differentiated thyroid cancer.
    Schmidt M; Antke C; Mattes-György K; Hautzel H; Allelein S; Haase M; Dringenberg T; Schott M; Ehlers M
    Clin Endocrinol (Oxf); 2021 Jun; 94(6):1004-1011. PubMed ID: 33484159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker.
    Zhang X; Li H; Yu X; Li S; Lei Z; Li C; Zhang Q; Han Q; Li Y; Zhang K; Wang Y; Liu C; Mao Y; Wang X; Irwin DM; Guo H; Niu G; Tan H
    Cell Physiol Biochem; 2018; 48(5):1983-1994. PubMed ID: 30092594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIS and epithelial-mesenchymal transition marker expression of circulating tumor cells for predicting and monitoring the radioactive iodine-131 therapy effect in differentiated thyroid cancers.
    Zheng L; Wang G; Guo W; Pan D; Xie L; He S; Luo C; Li H; Ran Y; Wu S; Liu F; Zhang X; Huang D
    Mol Biol Rep; 2019 Aug; 46(4):4201-4212. PubMed ID: 31147861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.
    Ning Y; Hanna DL; Zhang W; Mendez A; Yang D; El-Khoueiry R; Matsusaka S; Sunakawa Y; Stremitzer S; Parekh A; Okazaki S; Berger MD; Barzi A; Lenz HJ
    Mol Cancer Ther; 2015 Oct; 14(10):2401-8. PubMed ID: 26227487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer.
    Okabe H; Tsunoda S; Hosogi H; Hisamori S; Tanaka E; Tanaka S; Sakai Y
    Ann Surg Oncol; 2015 Nov; 22(12):3954-61. PubMed ID: 25777087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.